Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions.
OBJECTIVE
To describe the clinical features, neuropathology, and genetic studies in a family with autosomal dominant frontotemporal dementia (FTD).


BACKGROUND
Clinical Pick's disease, or FTD with parkinsonism, has been described in several families linked to chromosome 17 (FTDP-17). Most of these have shown tau protein mutations. The clinical and pathologic variations in these families resemble the spectrum of sporadic FTD or "Pick complex."


METHODS
Clinical and behavioral analysis of the affected members with extensive histochemical and neuropathologic description of three cases, genetic analysis of three clinically affected members and seven at risk members to assess linkage to chromosome 17, and sequencing of the tau gene in two patients were performed.


RESULTS
The clinical pattern shows a highly stereotypic disinhibition dementia with late extrapyramidal features, progressive mutism, and terminal dysphagia in three generations of affected individuals. Neuropathology showed frontotemporal atrophy, and microscopically tau- and synuclein-negative and ubiquitin-positive neuronal inclusions, in the background of superficial cortical spongiosis, neuronal loss, and gliosis. Tau expression was restricted to oligodendroglia. All exons and surrounding introns of the tau gene were sequenced, and no mutation or disease-related polymorphisms were detected in either of two affected pedigree members.


CONCLUSIONS
This family with autosomal dominant frontotemporal dementia (FTD) shows no tau expression in neurons. The ubiquitin-positive, tau-negative inclusions have been described before in FTD with and without motor neuron disease, but not in a familial form. The clinical and some pathologic features are similar to those of several of the families included in descriptions of FTD with parkinsonism linked to chromosome 17, but the linkage to tau has been excluded. The defect in this family, however, could be functionally related to tau mutations.
Kertesz
A
A
Department of Clinical Neurological Sciences, St. Joseph's Health Centre, University of Western Ontario, London, Canada. kertesz@lri.stjosephs.london.on.ca
Kawarai
T
T
Rogaeva
E
E
St George-Hyslop
P
P
Poorkaj
P
P
Bird
T D
TD
Munoz
D G
DG
D000328:Adult; D003704:Dementia / Q000235:genetics* / Q000473:pathology*; D005625:Frontal Lobe / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D002479:Inclusion Bodies / Q000473:pathology*; D008297:Male; D010375:Pedigree; D010641:Phenotype; D013702:Temporal Lobe / Q000473:pathology*; D014452:Ubiquitins / Q000032:analysis*; D016875:tau Proteins / Q000032:analysis*
D014452:Ubiquitins; D016875:tau Proteins